Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary
C

Covid-19, RNA-based Vaccine

Availability of ACE Drug Guidance

No

Biologics Drug Information Overview

Yes

Post-marketing information

Dear Healthcare Professional Letters

Subsidy Information and Financing Scheme

No

Active ingredients: Covid-19, RNA-based Vaccine | Covid-19 Vaccine | Vaccine Covid-19

General information

Subsidy Information and Financing Scheme

Not Applicable

Drug Guidance for Subsidy

Not Applicable

Post Marketing Information

DHCPL 18/05/2021 Interim authorisation of Pfizer-BioNTech COVID-19 Vaccine extended to include use in adolescents aged 12 to 15 years

DHCPL 03/02/2021 Interim authorisation of Moderna COVID-19 vaccine for active immunisation to prevent COVID-19 disease in Singapore

DHCPL 29/12/2020 Monitoring the safety profile of COVID-19 vaccines

DHCPL 14/12/2020 Interim authorisation of Pfizer-BioNTech COVID-19 vaccine (BNT162b2) for active immunisation to prevent COVID-19 disease in Singapore

View legend

General Availability in Public Healthcare Institution

Note:

General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.

Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration

Availability information

Formulation

Public Healthcare Institution

Comirnaty Injection 3 mcg/dose

  1. National University Hospital

Spikevax Injection, Solution 0.1 mg/mL

  1. National University Hospital

Comirnaty Injection (Single-Dose Vial) 30 mcg/dose

  1. National University Hospital

Comirnaty Injection (Single-Dose Vial) 10 mcg/dose

  1. National University Hospital

List of monographs containing this active ingredient

Covid-19, RNA-based Vaccine [Spikevax]

Covid-19, RNA-based Vaccine [Comirnaty]

Back to top